Mark Wilcox

20PUBLICATIONS
60CO-AUTHORS
Disease surveillanceMajor global burdens of diseaseBioprocessing, bioproduction and bioproductsImmunogenetics (incl. genetic immunology)Microbial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 02, 2025
Clostridioides difficile pathogenesis and control.

Caroline H Chilton, Virginie Viprey, Charmaine Normington

|Jul 24, 2024
Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source.

Jane Freeman, Virginie Viprey, Duncan Ewin

|Apr 23, 2024
Case Series: Efficacy of Polyclonal Intravenous Immunoglobulin for Refractory Clostridioides difficile Infection.

Sophie A Ragan, Caitlin Doyle, Neha Datta

|Feb 02, 2024
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response.

Pablo C Okhuysen, Mayur S Ramesh, Thomas Louie

Pageof 4